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AbstrAct
Objectives: The purpose of this study was to compare the quantity and quality of platelets in plate-
let-rich plasma (PRP) samples prepared using either the single- or the double-centrifugation proto-
col. 
Methods: Ten adult white New Zealand rabbits were used. Ten ml of blood were drawn from each 
animal via cardiac puncture. Each blood sample was divided into two equal parts for PRP prepara-
tion: 5 ml of blood were centrifuged according to a single-centrifugation protocol (Group I), and 5 ml 
were centrifuged according to a double-centrifugation protocol (Group II). Manual platelet counts 
were performed on the whole blood and PRP samples of each group. Smears were also done on all 
samples in order to see the morphology of the platelets. The data obtained in the manual platelet 
count were submitted to statistical analysis (repeated measures ANOVA, Tukey, P<.05).
Results: The average whole blood platelet count was 446,389/µl.  The PRP samples in Group II 
presented an average platelet amount significantly higher than that of Group I (1,986,875 ± 685,020/µl 
and 781,875 ± 217,693/µl, respectively). The PRP smears from Group II were the only one to present 
platelets with altered morphology (75% of the smears). A few lymphocytes with increased cytoplasm 
were observed in the PRP smears of both Groups I (25% of the smears) and II (62.5% of the smears).
Conclusions: Within the limits of this study, it can be concluded that the double-centrifugation pro-
tocol resulted in higher platelet concentrations than did the single-centrifugation protocol. However, 
the double-centrifugation protocol caused alterations in platelet morphology and was more sensitive 
to small processing errors. (Eur J Dent 2010;4:395-402) 
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Platelet-rich plasma (PRP) is a platelet con-
centrate in a small plasma volume. PRP also 
contains fibrin, fibronectin and vitronectin. These 
proteins are capable of enhancing cell adhesion 
and act like a matrix for the formation of bone, 
connective tissue and epithelium.1 Platelets con-
tain growth factors in their alfa granules, such 
as platelet-derived growth factor, transforming 
growth factor-β and insulin-like growth factor-I 
which, once released, may positively regulate the 
wound-healing process.1 
The therapeutic administration of PRP ranges 
from the treatment of multiple musculoskeletal 
disorders to the regeneration and accelerated 
healing of a wide range of tissues. However, there 
are controversies in the literature regarding the 
potential benefits of this procedure. Although 
some authors have reported significant improve-
ments in tissue healing and bone formation using 
platelet-rich plasma,2-6 others have not.7-10 Such 
discrepancies are probably related to the lack 
of suitable standardization and definition of the 
different PRP preparations.11 The protocols and 
surgical techniques used in the preparation and 
administration of the PRP differ widely.12,13 Varia-
tions in some key properties of the PRP, such as 
the platelet concentration, can greatly influence 
the different biological effects.11 
According to Whitman et al14 and Marx et al,15 
PRP is prepared by the discontinuous cell separa-
tion method from a blood volume of approximately 
450 ml.  However, this protocol for PRP prepara-
tion involves sophisticated technology and a large 
blood volume, limiting its use to blood transfusion 
medical centers or hospital facilities.16 Therefore, 
equipment capable of producing small amounts 
of PRP has become available commercially. This 
seems to have resulted in higher acceptance by 
patients because of lower cost and the feasibility of 
being conducted in non-hospital environments.17 
Several simplified protocols for the prepara-
tion of PRP have been developed to facilitate its 
clinical application.2,18,19 However, these protocols 
must be followed carefully, taking several techni-
cal issues into account. Basically, the centrifuga-
tion process for PRP preparation must be sterile 
and precisely suited to platelet separation from 
red blood cells and their sequestration in high 
IntroductIon concentrations without any damage or lysis that 
might  trigger  the  premature  release  of  GFs.1 It 
must be remembered that the PRP platelet count 
is strictly dependent on the type of protocol used 
for PRP preparation.20 According to Marx,1 PRP 
should have a platelet concentration 300 to 400% 
greater than that of the whole blood in order to be 
considered a “therapeutic PRP.” Lower concen-
trations are reportedly unreliable in enhancing 
wound healing, while higher concentrations have 
not been shown to further enhance wound heal-
ing.21 
Marx et al15 stated that a double-centrifugation 
technique is necessary to truly concentrate plate-
lets from autologous blood. On the other hand, 
Anitua2,22  described using a single-spin technique, 
although the platelet concentrations obtained by 
this procedure were not reported. In spite of the 
amount of platelets, Anitua has demonstrated en-
hancement and acceleration of bone regeneration 
and more rapid and predictable soft tissue heal-
ing in future sites for implants that were treated 
with PRP prepared according to a single-spin 
technique.2 Other authors have reported obtaining 
platelet concentrations of 356% using the single-
spin technique.23 
The purpose of this study was to compare the 
quantity and quality of platelets in PRP samples 
prepared using either the single- or the double-
centrifugation protocol in an animal model.
 
MAtErIALs And MEtHods
Experimental model
The experimental protocol was approved by 
the São Paulo State University, UNESP, Dental 
School of Araçatuba Institutional Animal Care and 
Use Committee.  Ten adult male white New Zea-
land rabbits weighing 2.8 to 4 kg (UNESP, Dental 
School of Araçatuba, Animal Care Unit) were used 
in this study. An endoparasitosis control program, 
including vaccination, vermifungal treatment regi-
men and balanced diet was instituted. The animals 
were housed in individual cages at room tempera-
ture and were fed solid chow and water ad libitum.
 
Anesthesia
The animals were anesthetized by intramus-
cular injection of xylazine (10 mg/kg body weight) 
and ketamine (1.5 mg/kg body weight).
   Autologous platelet-rich plasmaOctober 2010 - Vol.4
397
European Journal of Dentistry
PRP preparation 
a) Cardiac puncture and blood sample col-
lection: A 10 ml volume of autologous blood was 
drawn from each animal via cardiac puncture. 
Each blood sample was divided into two 5 ml vac-
uum tubes containing 10% sodium citrate. One 
milliliter of the blood was separated for platelet 
count. The two 5 ml blood samples were randomly 
assigned to one of the following groups: Group I, 
in which the PRP was prepared according to a sin-
gle-centrifugation protocol,2 or Group II, in which 
the PRP was prepared according to a double-cen-
trifugation protocol.19  
b) Protocol for PRP preparation in Group I: The 
separation of the blood cell elements was per-
formed using a laboratory centrifuge (Beckman 
J-6M Induction Drive Centrifuge, Beckman Instru-
ments Inc., Palo Alto, CA, USA). The blood samples 
were centrifuged at 160 G for 6 minutes at room 
temperature resulting in three basic components: 
red blood cells (bottom of the tube), PRP (middle 
of the tube) and platelet-poor plasma (PPP) (top of 
the tube). One milliliter of PPP was pipetted and 
discarded. Next, a mark was made 2 mm below 
the line separating the middle component from 
the lower component of the tube. All content above 
this point (approximately 1.2 ml) was pipetted and 
comprises the volume of PRP.
c) Protocol for PRP preparation in Group II:
First centrifugation: The separation of the 
blood cell elements was performed using a labo-
ratory centrifuge (Beckman J-6M Induction Drive 
Centrifuge, Beckman Instruments Inc., Palo Alto, 
CA, USA). The tubes were centrifuged at 160 G for 
20 minutes at room temperature resulting in two 
basic components: blood cell component (BCC) in 
the lower fraction and serum component (SEC) in 
the upper fraction. 
Second centrifugation: A mark was made 6 
mm below the line that separated the BCC from 
the SEC. To increase the total amount of platelets 
collected for the second centrifugation, all content 
above this point was pipetted and transferred to 
another 5 ml vacuum tube without anticoagulant. 
The sample was then centrifuged again at 400 G 
for 15 minutes resulting in two components: SEC 
and PRP. The PRP (approximately 0.5 ml) was 
separated from the SEC.
Platelet count study 
The platelets in the whole blood and PRP sam-
ples from Groups I and II were counted manually 
in the Neubauer chamber. Brecher liquid was 
used to lyse the erythrocytes. Two parameters, 
based in part on the study by Tamimi et al,21 were 
evaluated for the PRP samples: platelet increase 
compared to whole blood and platelet concentra-
tion. These values were calculated using the fol-
lowing equations:  
% platelet increase over whole blood = 
Platelet count of PRP - Platelet count of whole blood 
  Platelet count of whole blood 
Platelet concentration (%) =   
     Platelet count of PRP                                     
      Platelet count of whole blood
PRP and whole blood were also used to per-
form smears which were stained with “Panótico 
Rápido LB” (LaborClin, Pinhais, PR, Brazil) in or-
der to reveal the morphology of the blood cells and 
platelets. The platelet counts and the analysis of 
the platelet morphology were performed by a vet-
erinary hematologist blinded to the PRP prepara-
tion protocol used.
 
Statistical analysis
The significance of differences between the 
whole blood and the PRP platelet counts as well 
as between the PRP platelet counts of Groups I 
and II was determined by an analysis of variance 
(repeated measures ANOVA), followed by a post 
hoc Tukey’s test when the ANOVA suggested a sig-
nificant difference between groups (P<.05). 
Pearson’s correlation coefficient (rp) was used 
to demonstrate the relationship between the 
platelet counts from the PRP and whole blood 
samples of Groups I and II.
 
rEsuLts
Platelet count study
Two animals were excluded from the study 
after blood centrifugation for PRP preparation in 
Group I. The low PPP volume in these samples did 
not allow for preparation of the PRP as specified in 
the single-centrifugation protocol.
The PRP smears of both Groups I and II showed 
higher concentrations of platelets than their re-
X 100 
X 100 
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spective whole blood smears (Figure 1). In both 
groups, numerous packed red blood cells were 
seen surrounding compact round platelet aggre-
gates. Only the PRP smears from Group II pre-
sented platelets with altered morphology. From 
eight PRP smears analyzed from each group, six 
PRP smears of Group II showed some deformed 
platelets suggestive of elongated pseudopodia 
(Figure 2). A few lymphocytes with increased cy-
toplasm were observed in the PRP smears of both 
Groups I (2 PRP smears) and II (5 PRP smears) 
(Figure 3). 
The average whole blood platelet count was 
454,68  ±  181,538/µl.  The  average  PRP  platelet 
count in Group I was 781,875 ± 217,693/µl, whereas 
it was 1,986,875 ± 685,020/µl in Group II (Figure 4). 
Significant differences were observed between the 
platelet counts from the PRP samples of Groups I 
and II (P<.05). Significant differences between the 
whole blood and PRP platelet counts were ob-
served only in Group II (P<.05). A significant cor-
relation was observed between the platelet count 
from the whole blood and PRP samples in Groups 
I (rp=0.93, P=0.002) and II (rp=0.89, P=0.0010)  
Platelet concentration of PRP and platelet in-
crease over whole blood samples between Groups 
I and II are depicted in Table 1. The percentage in-
crease in the platelet count of PRP compared to 
whole blood was higher in Group II than in Group 
I (Table 1). 
Figure 1. Whole blood and PRP smears showing platelet aggregates (arrows). Whole blood (A), PRP smear of Group I (B) and PRP smear of Group II (C). (Panótico Rápido 
LB staining; original magnification x1000)
Figure 2. PRP smears (Group II) showing platelets (arrows) with altered morphology. (Panótico Rápido LB staining; original magnification x1000)
Figure 3. PRP smears of Group I (A) and Group II (B) showing white blood cells (arrows). (Panótico Rápido LB staining; original magnification x1000)
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dIscussIon
Different PRP preparation protocols may result 
in varying platelet concentrations, and thus differ-
ent biologic effects may occur.21,24,25 The platelet 
count should be one of the key factors by which 
to standardize studies investigating the regenera-
tive capacity of PRP.26 In addition, qualitative al-
terations in the platelets may also affect the re-
generative potential of PRP.27 According to Marx,1 
platelets damaged or rendered nonviable by the 
protocol used to process the PRP will not secrete 
bioactive growth factors. Thus, the resulting out-
come may be disappointing. The present study 
evaluated both the quantity and quality of platelets 
in PRP samples prepared according to two differ-
ent protocols.
According to Marx, a “therapeutic PRP” should 
present approximately one million platelets per 
microliter in humans, considering that the whole 
blood contains approximately 200,000 ± 75,000 
platelets per microliter. Therefore, a “therapeutic 
PRP” is one that has an average percentage in-
crease of approximately 400% in the platelet count. 
Studies in dogs and rabbits have demonstrated 
that a 4-fold increase in the platelet concentration 
was effective in accelerating bone healing.25,28 In 
the present study, the animals showed an average 
whole  blood  platelet  count  of  446,389  platelets 
per microliter, which is within the normal range 
for the animal model used.29 In this study, only the 
double  centrifugation  protocol  used  in  Group  II 
produced a “therapeutic PRP” (Table 1).  
The low platelet concentrations obtained in the 
PRP samples of Group I are most likely attribut-
able to the fact that only a single centrifugation 
was used in this protocol. According to Marx, cli-
nicians should use either a double-centrifugation 
technique or some other FDA approved system 
specifically developed for PRP preparation.1,30
In the double-centrifugation protocol, the first 
spin (called the hard spin) separates the red blood 
cells from the plasma, which contains the plate-
lets, the white blood cells and the clotting fac-
tors. The second spin (called the soft spin) further 
separates the platelets, white blood cells and few 
remaining red blood cells from the plasma. In 
contrast, a single spin would not produce a true 
PRP. Instead, it would produce a mixture of PRP 
and PPP, resulting in disappointingly low platelet 
concentrations.1 In the present study, the double-
Figure 4. Whole blood and PRP platelet counts and Standard Deviations for Groups I and II, as well as the results of the comparison among the groups.  * indicates statisti-
cally significant difference (P<.05).
  Group I Group II
Parameter  Mean±SD  Mean±SD
Platelet concentration of PRP (platelets/µl) 180.73±31.01 447.68±58.00
Platelet increase over the whole blood (%) 80.73±31.01  347.68±58.00
Table 1. Platelet concentration of PRP and platelet increase over whole blood samples between groups I and II. 
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centrifugation protocol yielded increases in plate-
let concentrations similar to those obtained in hu-
mans with two systems developed specifically for 
PRP preparation (PCCS, 3i, Inc., Palm Beach Gar-
dens, FL, USA and “SmartPrep,” Harvest Technol-
ogies, Plymouth, MA, USA).1
In addition to the number of centrifugations, 
there are several important factors that should 
be considered with regard to the PRP preparation 
method chosen.  The force of gravity (G) used in 
the centrifugation process is one. An increase in 
G may result in higher platelet concentrations.3 In 
the present study, blood centrifugation at 400 G 
(Group II) provided a significantly higher platelet 
concentration than did blood centrifugation at 160 
G (Group I). However, it is important to remember 
that increasing the G used for the centrifugation 
may prematurely activate the platelets.31 Platelets 
can also be prematurely activated by excessive 
pipetting32,33 or by the type of anticoagulant used 
during the preparation of PRP.29,30  
The effects of the protocol to prepare PRP on 
the quality of the concentrated platelets were 
evaluated in this study through platelet smear 
analysis. Smears are valid to evaluate many pa-
rameters that are indicative of platelet function, 
such as changes in morphology, size, shape, 
staining characteristics, degree of activation and 
clump formation, distribution of granules and ap-
pearance of vacuoles.34 In the present study, the 
PRP smears of Group II showed some deformed, 
round-shaped platelets which may indicate pre-
mature platelet activation. Premature activation 
would lead to an early release of growth factors, 
causing them to move to the top of the tube when 
centrifuged. Thus, the resultant PRP would be 
poor in growth factors.21 Since the levels of growth 
factors present in the PRP samples of the pres-
ent study were not measured, further studies are 
required to confirm this hypothesis. 
Additionally, the PRP smears of both groups 
had some lymphocytes with increased cytoplasm. 
This observation is consistent with activation of the 
immune response resulting in increased synthe-
sis and release of cytokines by white blood cells, 
which could prematurely activate platelet degran-
ulation and thus cause a decrease in the number 
of growth factors present at the time the PRP is 
placed.21 A recent in vivo study lends support to 
this hypothesis. Radiographic and histomorpho-
metric analyses were conducted to evaluate bone 
healing in the calvaria of rabbits following the use 
of autogenous grafts combined with PRP obtained 
by either a single- or double-centrifugation pro-
tocol.35 The combination of PRP with autogenous 
bone did not improve the initial healing process, 
irrespective of the PRP preparation protocol used. 
According to the authors, both protocols may have 
harmed platelets or caused them to degranulate 
prematurely, thus reducing the effect of PRP.
From a clinical standpoint, a second impor-
tant consideration is that the platelet concentra-
tion process used to prepare the  PRP  be very 
reliable.20  Both protocols evaluated in the pres-
ent study showed a high correlation between the 
whole blood and PRP platelet counts (Group I - 
rp=0.93 and Group II - rp=0.89). Therefore, the level 
of correlation between these two parameters sug-
gests that the whole blood platelet count can be 
used as an estimate of the platelet count likely to 
be produced by the two protocols evaluated in this 
study.
Significant variations in hematocrit between 
subjects must also be considered when choosing 
a method of PRP preparation. The single-centrif-
ugation protocol used in this study did not result 
in any PRP being produced in two animals whose 
samples had a total plasma volume smaller than 
1 ml after blood centrifugation because the proto-
col requires that 1 ml of PPP be discarded.  After 
pipetting and discarding the upper layer of PPP, 
there was only the RBC layer left.  However, the 
double-centrifugation protocol was able to pro-
duce PRP in both animals.   
It is important to emphasize that, in this study, 
the final volume of the PRP samples in Groups I 
and II were different (1.2 ml and 0.5 ml, respec-
tively). According to Efeoglu et al,29 the platelet 
concentration may be higher in a small volume 
of plasma than in a greater volume of plasma. 
The findings of the present study corroborate this 
statement because the protocol used in Group II 
led to a significantly greater amount of platelets in 
PRP samples than the one obtained in PRP sam-
ples of Group I.
The selection of the animal model used is also 
very important because some have blood volumes 
too small to produce autologous PRP, thus neces-
sitating the use of donor blood for the PRP prepa-
ration protocol. The use of homologous PRP could 
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compromise the reliability of the results of those 
studies because, according to Marx,1 only autolo-
gous PRP is true PRP. In the present study, PRP 
was prepared using a small blood volume (10 ml). 
The total amount of blood that can be collected 
from an adult New Zealand rabbit without risking 
its life is limited to 15 ml.29 Therefore, the amount 
of blood collected in this study allowed autologous 
PRP preparation without causing any systemic 
problems. New Zealand rabbits are also easy to 
obtain and can be cared for at affordable prices. 
This makes them a favorable alternative in experi-
mental studies investigating the biological effects 
of PRP.29   
Finally, the platelet count method used in this 
study was important as well since there is no con-
sensus regarding the ideal method to quantify this 
blood element. Studies have raised doubts about 
the level of agreement between manual and auto-
mated platelet counts.35-39 Although some authors 
have discussed the advantages of automated 
platelet counts,40 others have concluded that this 
method is less reliable than manual counts, espe-
cially in cases of thrombocytopenia.36,37 Therefore, 
manual platelet counts were used in the present 
study.
concLusIons
The controversies regarding the influence of 
PRP on wound healing should be re-examined, 
taking into consideration many variables including 
the protocol used for PRP preparation. Within the 
limits of this study, it can be concluded that the 
double-centrifugation protocol used in this study 
achieved higher platelet concentrations than did 
the single-centrifugation protocol used in this 
study. However, the double-centrifugation proto-
col caused alterations in platelet morphology and 
was more sensitive to small processing errors. 
Due to the small n numbers in each study group, 
the present results should be accepted as prelimi-
nary.
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